ProQR Therapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $8,904 | $2,066 | $4,644 | $2,915 |
Gross Profit | 8,185 | 1,361 | 3,971 | 2,915 |
EBITDA | -8,249 | -12,897 | -8,366 | -10,335 |
EBIT | -8,968 | -13,603 | -9,039 | -11,006 |
Net Income | -8,872 | -13,603 | -8,836 | -11,006 |
Net Change In Cash | 8,904 | 2,066 | 4,644 | 2,915 |
Free Cash Flow | -12,697 | -11,309 | -13,593 | -12,404 |
Cash | 117,076 | 93,429 | 92,373 | 125,587 |
Basic Shares | 109,958 | 105,362 | 103,011 | 110,060 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $15,278 | $18,905 | $6,514 | $3,594 |
Gross Profit | 12,681 | 18,905 | 6,514 | 3,594 |
EBITDA | -37,038 | -24,122 | -24,097 | -56,460 |
EBIT | -39,634 | -26,883 | -26,610 | -58,981 |
Net Income | -40,519 | -27,763 | -28,119 | -64,424 |
Net Change In Cash | 15,278 | 18,905 | 6,514 | 3,594 |
Free Cash Flow | -53,811 | -37,811 | 20,177 | -69,216 |
Cash | 108,534 | 154,711 | 131,370 | 101,148 |
Basic Shares | 105,334 | 81,665 | 81,011 | 71,641 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.10 |
2026-03-31 | -$0.15 |
2025-12-31 | -$0.09 |
2025-09-30 | -$0.12 |